MLKL and cholangiocarcinoma: Interestingly, while MLKL expression is typically associated with poor prognosis, studies on cholangiocarcinoma reveal a positive correlation between MLKL-activated necroptosis and favorable immune cell features, including elevated PD-L1 expression.